Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Ring chromosome 2 syndrome is a rare chromosomal anomaly syndrome with highly variable phenotype principally characterized by intrauterine growth retardation, failure to thrive, developmental delay, hypotonia, mild dysmorphic features (incl. microcephaly, short forehead, upslanting palpebral fissures, hypertelorism, epicanthal folds, wide nasal bridge, broad nasal tip, long philtrum, thin upper lip, micrognathia, short neck), skeletal anomalies (e.g. kyphosis, brachydactyly, clinodactyly, talipes equinovarus) and dermatological features (i.e. café-au-lait spots). Patients may also present ventriculoseptal defects and genital abnormalities (e.g. genital hypoplasia, phimosis, cryptorchidism).
Biomarker and diagnostic research for ring chromosome 2 has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for ring chromosome 2.
164 publications have been identified in PubMed for ring chromosome 2. Research spans Basic Science / Preclinical (37%), Epidemiology / Natural History (35%), and Clinical Trial Publication (13%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 58 | 37% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 12:11 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
55 |
35% |
Clinical study results | 20 | 13% |
Research summaries | 9 | 6% |
New treatment approaches | 6 | 4% |
Testing and diagnosis research | 4 | 3% |
Patient case studies | 3 | 2% |
Other research | 1 | 1% |
Vlegels N (2026). [PMID: 41533774](https://pubmed.ncbi.nlm.nih.gov/41533774/). *Sci Transl Med*. [Epidemiology / Natural History]
Elizabeth MV (2026). [PMID: 41538134](https://pubmed.ncbi.nlm.nih.gov/41538134/). *Luminescence*. [Basic Science / Preclinical]
SanInocencio C (2026). [PMID: 41533279](https://pubmed.ncbi.nlm.nih.gov/41533279/). *Qual Life Res*. [Gene Therapy / Novel Therapeutics]
Karume AK (2026). [PMID: 42275413](https://pubmed.ncbi.nlm.nih.gov/42275413/). *PLoS One*. [Clinical Trial Publication]
Feng S (2026). [PMID: 41888674](https://pubmed.ncbi.nlm.nih.gov/41888674/). *BMC Infect Dis*. [Basic Science / Preclinical]
Chen J (2026). [PMID: 41062253](https://pubmed.ncbi.nlm.nih.gov/41062253/). *Br J Ophthalmol*. [Clinical Trial Publication]
Patel M (2026). [PMID: 42127933](https://pubmed.ncbi.nlm.nih.gov/42127933/). *Lancet Neurol*. [Basic Science / Preclinical]
Miro JM (2026). [PMID: 40907699](https://pubmed.ncbi.nlm.nih.gov/40907699/). *Clin Microbiol Infect*. [Clinical Trial Publication]
Aczel B (2026). [PMID: 41922703](https://pubmed.ncbi.nlm.nih.gov/41922703/). *Nature*. [Basic Science / Preclinical]
Lu X (2026). [PMID: 41484691](https://pubmed.ncbi.nlm.nih.gov/41484691/). *J Health Popul Nutr*. [Epidemiology / Natural History]